{"id":1323,"date":"2023-09-26T15:01:42","date_gmt":"2023-09-26T18:01:42","guid":{"rendered":"https:\/\/csan2023.saneurociencias.org.ar\/index.php\/2023\/09\/26\/193-study-of-melanin-concentrating-hormone-mch-and-glutamatergic-systems-in-the-streptozotocin-stz-induced-alzheimers-disease-ad-model-in-male-rats\/"},"modified":"2023-09-26T20:38:48","modified_gmt":"2023-09-26T23:38:48","slug":"193-study-of-melanin-concentrating-hormone-mch-and-glutamatergic-systems-in-the-streptozotocin-stz-induced-alzheimers-disease-ad-model-in-male-rats","status":"publish","type":"post","link":"https:\/\/csan2023.saneurociencias.org.ar\/index.php\/2023\/09\/26\/193-study-of-melanin-concentrating-hormone-mch-and-glutamatergic-systems-in-the-streptozotocin-stz-induced-alzheimers-disease-ad-model-in-male-rats\/","title":{"rendered":"193 | Study of melanin-concentrating hormone (MCH) and glutamatergic systems in the streptozotocin (STZ)-induced Alzheimer&#8217;s disease (AD) model in male rats."},"content":{"rendered":"<p>Disorders of the Nervous System<\/p>\n<p><strong>Author:<\/strong> Sof\u00eda Ni\u00f1o | <strong>Email:<\/strong> sofianino1994@gmail.com<\/p>\n<hr \/>\n<p>Sof\u00eda Ni\u00f1o Rivero <sup>1\u00b0<\/sup>, Marialuisa de Ceglia <sup>2\u00b0<\/sup>, Ana Luisa Gavito <sup>2\u00b0<\/sup>, Fernando Rodr\u00edguez de Fonseca <sup>2\u00b0<\/sup>, Jessika Urbanavicius <sup>3\u00b0<\/sup>, Patricia Lagos <sup>1\u00b0<\/sup><\/p>\n<p>1\u00b0 Unidad Acad\u00e9mica de Fisiolog\u00eda, Facultad de Medicina, Universidad de la Rep\u00fablica, Montevideo, Uruguay<br \/>\n2\u00b0 UGC Salud Mental, Instituto de Investigaci\u00f3n Biom\u00e9dica de M\u00e1laga, Hospital Regional Universitario de M\u00e1laga, Universidad de M\u00e1laga, M\u00e1laga, Spain.<br \/>\n3\u00b0 Departamento de Neurofarmacolog\u00eda Experimental, Instituto de Investigaciones Biol\u00f3gicas Clemente Estable, Ministerio de Educaci\u00f3n y Cultura, Montevideo, Uruguay.<\/p>\n<p>MCH is a hypothalamic neuropeptide that regulates memory, although with contradictory effects. In agreement, it has been postulated to be involved in AD neuropathological mechanisms. In this work, we study behavioral and molecular changes in the MCHegic system in the STZ-induced AD model. Considering the impact of AD on the glutamatergic system, we evaluated markers in our model that are poorly studied. Cognitive performance were evaluated in intracerebroventricularly STZ or vehicle administered male rats in the Novel Object Recognition (NOR) at 15, 30, 60, 90 or 120 days post-administration. After that, we evaluated MCH levels in cerebrospinal fluid (CSF) by ELISA and MCH receptor 1 expression (immunofluorescence or western blot) in hippocampus or hypothalamus. Regarding the glutamatergic system, we measured NMDA 2A and 2B receptor subunit in hippocampus. We found that cognitive deficits appeared later, T90 and T120. MCH CSF levels were similar at all the stages studied and MCHR-1 expression at primary cilia of hippocampal neurons or protein levels did not shown differences between STZ and control group. However, in the hypothalamus we found increased MCHR-1 expression at T30, 90 and 120. In terms of the glutamatergic system, 2A subunit were significantly increased at T15 and T60. Meanwhile, 2B levels decreased at the later T120 time point. Our results suggest that in this AD model, MCHergic system is modified at hypothalamus whereas the glutamatergic system at hippocamppus<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Author: Ni\u00f1o Sof\u00eda | email: sofianino1994@gmail.com | Disorders of the Nervous System<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[17],"tags":[22],"class_list":["post-1323","post","type-post","status-publish","format-standard","hentry","category-session-1","tag-disorders-of-the-nervous-system"],"_links":{"self":[{"href":"https:\/\/csan2023.saneurociencias.org.ar\/index.php\/wp-json\/wp\/v2\/posts\/1323","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/csan2023.saneurociencias.org.ar\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/csan2023.saneurociencias.org.ar\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/csan2023.saneurociencias.org.ar\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/csan2023.saneurociencias.org.ar\/index.php\/wp-json\/wp\/v2\/comments?post=1323"}],"version-history":[{"count":3,"href":"https:\/\/csan2023.saneurociencias.org.ar\/index.php\/wp-json\/wp\/v2\/posts\/1323\/revisions"}],"predecessor-version":[{"id":1809,"href":"https:\/\/csan2023.saneurociencias.org.ar\/index.php\/wp-json\/wp\/v2\/posts\/1323\/revisions\/1809"}],"wp:attachment":[{"href":"https:\/\/csan2023.saneurociencias.org.ar\/index.php\/wp-json\/wp\/v2\/media?parent=1323"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/csan2023.saneurociencias.org.ar\/index.php\/wp-json\/wp\/v2\/categories?post=1323"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/csan2023.saneurociencias.org.ar\/index.php\/wp-json\/wp\/v2\/tags?post=1323"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}